MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Covidien logs first patient in Iliac stent studies | Research Roundup

Covidien logs first patient in Iliac stent studies | Research Roundup

By

Covidien

Covidien Plc. (NYSE:COV) enrolled the first patients into its two Iliac stent trials, Durability and Visibility.

The trials will each enroll 75 patients at up 20 centers in Europe and the U.S. in order to test the safety and effectiveness of Mansfield, Mass.-based Covidien’s Iliac stent systems for patients with peripheral arterial disease.

Both studies have started in Belgium, enrolling patients at AZ St-Blasius in Dendermonde and Imelda Hospital in Bonheiden.

Covidien ranked 9th on the MassDevice Big 100 list of the world’s largest medical device companies.

The Durability trial will test the Protege EverFlex self-expanding stent with delivery technology, and the Visibility study will test the Visi-Pro balloon expandable stent systems.

Visi-Pro and Protege are already available in the U.S. as treatments for malignant neoplasts in the biliary tree, according to the press release, but the studies hope to expand the indications to PAD treatment in the iliac arteries.

Listen to our exclusive podcast of MassDevice publisher Brian Johnson’s intimate interview with Covidien CEO Joe Almeida.

M and A Roundup

Here’s a roundup of recent clinical trial and scientific study news:

  • Artificial lungs inch closer to the real thing by casting aside oxygen tanks
    The next generation of artificial lungs may be able to use air instead of pure oxygen that current man-made lungs require, according to researchers at Case Western Reserve University in Cleveland, Ohio. The device is still years away from human use, but researchers say that by the time it’s ready it’ll only be about the size of a human lung, or around 6 inches by 6 inches by 4 inches.
    Read more

  • Biotronik completes enrollment in 4Ever study, begins enrollment in stent study
    Biotronik AG has been busy with trials in the last month, announcing closed enrollment of its 4Ever study and opening enrollment for its BioFlow II study. The 4Ever study enrolled 120 patients into a physician-initiated trial of the Switzerland-based company’s Astron Pulsar and Pulsar-18 stents in treatment of superficial femoral artery lesions. The stent trial will study about 440 patients to compare Biotronik’s Orsiro drug-eluting stent to Abbott’s (NYSE:ABT) Xience Prime stent.
    Read more

  • Heart pumps are okay for the elderly

    Left ventricular assist devices led to better quality of life in patients over the age of 70, according to a study published in the June issue of the
    Journal of the American College of Cardiology. Patients were implanted with Thoratec Corp.’s (NSDQ:THOR) HeartMate II LVAD, which won FDA clearance in April 2008.
    Read more

    • In case you missed it

    RSS From Medical Design & Outsourcing

    • 6 power management considerations for developing and scaling smaller, smarter micromedical devices
      Supercharge every phase of micromedical device product development with these questions. Mitch Johnson, Intricon Some of the biggest considerations for designing, manufacturing and scaling today’s smaller, smarter medical innovations center on providing power to microelectronic systems. From mechanical functionality to data operations and wireless communications, effective power management drives continued device innovation. Addressing five fundamental… […]
    • Evonik, Coopmed agree on wound dressing distro deal
      Evonik announced today that it signed an agreement for medical technology company Coopmed to distribute the epicite wound dressing. Jena, Germany-based Evonik said Coopmed will distribute the epicite dressing made from biosynthetic cellulose exclusively to the German market for chronic wound care. Epicite represents part of the portfolio from JeNaCell, which Evonik acquired in 2021.… […]
    • Spartech hires Bosch VP Dan Gallo as chief operating officer
      Spartech today said it hired Dan Gallo as chief operating officer of the engineered thermoplastics and custom packaging manufacturer. Gallo started this month, according to his LinkedIn page. His career leading operations, supply chain and logistics functions spans more than three decades. He was most recently an operations VP at Robert Bosch. Before his time… […]
    • 3M launches Verify platform to spot counterfeit products
      3M (NYSE:MMM) announced today that it established a new 3M Verify platform to report potential counterfeit 3M products. The effort builds upon its anti-counterfeit efforts during the height of the COVID-19 pandemic. At the time, a number of sellers claimed to offer 3M respirators. Instead, many offered fake, defective and damaged N95 masks at inflated… […]
    • FDA will review fewer COVID-19 test EUA submissions
      The FDA is pushing COVID-19 test developers away from emergency use authorization (EUA) submissions in favor of more traditional pathways, the agency said today. The FDA said it intends to review “only a small subset” of new EUA submissions, encouraging test makers to seek regulatory approval through de novo classification or 510(k) clearance pre-market review… […]
    • Integra plans to shrink the C-suite after executive’s exit
      Integra Lifesciences (Nasdaq: IART) will eliminate the position of chief operating officer next week — though the office is already empty. Former COO Glenn Coleman’s last day at Integra was Friday, according to a separation agreement filed with the Securities and Exchange Commission that same day. Coleman was scheduled to start as the new EVP and… […]
    • Steris plans to build a new medical device testing facility
      Steris (NYSE: STE) plans to build a new packaging and microbiological testing facility for medical devices in Leipzig, Germany. The facility will offer packaging testing services such as accelerated and real-time aging, transportation and integrity testing. The new location will also offer microbiological testing in collaboration with the medical device manufacturer and sterilizer’s laboratory in… […]
    • 10 medical device startups you need to know
      Some of the most interesting medical device startups of 2022 are advancing a wide range of innovative medtech: robotics, catheter-delivered brain-computer interfaces and more. The editors here at Medical Design & Outsourcing and MassDevice are writing about medical device startups all the time. But there are some device companies starting out that have technologies that… […]
    • Steris stock downgraded as analysts expect lawyers to seek more ethylene oxide lawsuits
      Steris (NYSE: STE) stock was downgraded today by Needham from buy to hold following the $363 million jury verdict against its primary competitor, Sterigenics, over ethylene oxide (EtO) emissions. Needham analysts said they expect attorneys to target communities near EtO facilities with ads to find people willing to file more lawsuits against sterilization plant operators… […]
    • Researchers develop at-home device to track Parkinson’s progression
      Researchers at MIT and the University of Rochester Medical Center have developed a device to monitor a Parkinson’s patient at home. Collecting data at home could help provide a less subjective measurement than evaluations at the doctor’s office, which can be affected by outside factors. The technology could also help pharmaceutical and biotech companies developing… […]
    • Micro Mold renovates for new 5-axis milling center
      Precision mold maker Micro Mold has renovated in Erie, Pennsylvania, to make room for its new Yasda YMC650 high-speed 5-axis milling center and 3R Workpartner automation cell. The new equipment will be used for electrode manufacturing and finishing hard mill applications. The milling machine is accurate to 1 micron for high-volume, ultra-precision tooling work, the… […]

    Leave a Reply